Biotechnology
PBYI
5.04
price down icon1.18%   -0.06
pre-market  Vorhandelsmarkt:  5.06   0.02   +0.40%

Puma Biotechnology Inc (PBYI)
full-star
loading
Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose
Schlusskurs vom Vortag:
$5.10
Offen:
$5.13
24-Stunden-Volumen:
490.98K
Relative Volume:
0.78
Marktkapitalisierung:
$253.87M
Einnahmen:
$230.47M
Nettoeinkommen (Verlust:
$30.28M
KGV:
8.2623
EPS:
0.61
Netto-Cashflow:
$38.86M
1W Leistung:
-4.36%
1M Leistung:
-1.75%
6M Leistung:
+57.01%
1J Leistung:
+70.85%
1-Tages-Spanne:
Value
$5.00
$5.22
1-Wochen-Bereich:
Value
$5.00
$5.515
52-Wochen-Spanne:
Value
$2.32
$6.07

Puma Biotechnology Inc Stock (PBYI) Company Profile

Name
Firmenname
Puma Biotechnology Inc
Name
Sektor
Healthcare (1136)
Name
Branche
Biotechnology (633)
Name
Telefon
(424) 248-6500
Name
Adresse
10880 WILSHIRE BLVD., LOS ANGELES, CA
Name
Mitarbeiter
172
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
PBYI's Discussions on Twitter

Vergleichen Sie PBYI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
PBYI
Puma Biotechnology Inc
 5.04 256.89M 230.47M 30.28M 38.86M 0.61
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
 826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
 186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-09-28 Hochstufung Citigroup Neutral → Buy
2020-06-25 Fortgesetzt BofA/Merrill Underperform
2019-10-08 Herabstufung Goldman Neutral → Sell
2019-05-10 Herabstufung Cantor Fitzgerald Overweight → Neutral
2019-05-10 Herabstufung Citigroup Buy → Neutral
2019-01-17 Eingeleitet Leerink Partners Mkt Perform
2019-01-03 Herabstufung Guggenheim Buy → Neutral
2018-11-19 Hochstufung Goldman Sell → Neutral
2018-11-02 Herabstufung BofA/Merrill Buy → Underperform
2018-11-02 Herabstufung JP Morgan Neutral → Underweight
2018-10-01 Eingeleitet Cantor Fitzgerald Overweight
2018-09-17 Eingeleitet Goldman Sell
2018-05-11 Bestätigt Stifel Buy
2017-11-10 Bestätigt Citigroup Buy
2017-11-10 Bestätigt RBC Capital Mkts Sector Perform
2017-10-02 Bestätigt Stifel Buy
2017-09-11 Bestätigt Credit Suisse Outperform
2017-07-10 Fortgesetzt Leerink Partners Outperform
2017-06-06 Bestätigt RBC Capital Mkts Sector Perform
2017-05-25 Bestätigt RBC Capital Mkts Sector Perform
2017-03-02 Bestätigt RBC Capital Mkts Sector Perform
Alle ansehen

Puma Biotechnology Inc Aktie (PBYI) Neueste Nachrichten

pulisher
02:24 AM

Using fundamentals and technicals on Puma Biotechnology Inc.Trade Exit Summary & Low Risk Profit Maximizing Plans - newser.com

02:24 AM
pulisher
Nov 03, 2025

Using R and stats models for Puma Biotechnology Inc. forecastingQuarterly Risk Review & Safe Capital Growth Stock Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How strong is Puma Biotechnology Inc. stock revenue growthMarket Performance Report & AI Forecast for Swing Trade Picks - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using Ichimoku Cloud for Puma Biotechnology Inc. technicalsPortfolio Profit Report & Daily Oversold Bounce Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How institutional buying supports Puma Biotechnology Inc. stockMarket Activity Report & Daily Oversold Bounce Ideas - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Is Puma Biotechnology Inc. reversing from oversold territoryJuly 2025 Levels & Verified Chart Pattern Trade Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can Puma Biotechnology Inc. stock withstand economic slowdown2025 Historical Comparison & AI Enhanced Trading Signals - newser.com

Nov 02, 2025
pulisher
Oct 31, 2025

Global Desmoid Tumors Market Report 2025: Regional and Country-Level Analysis & Forecast to 2035 Featuring SpringWorks Therapeutics, Ayala Pharma, Puma Biotechnology, BMS, Eli Lilly, Ipsen, Deciphera Pharma - Yahoo Finance

Oct 31, 2025
pulisher
Oct 31, 2025

Puma Biotechnology (PBYI) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2025
pulisher
Oct 28, 2025

Will Puma Biotechnology Inc. stock remain a Wall Street favorite - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 27, 2025

Why retail investors favor Puma Biotechnology Inc. stockInflation Watch & Safe Entry Momentum Tips - fcp.pa.gov.br

Oct 27, 2025
pulisher
Oct 27, 2025

Puma Biotechnology Stock Up 11%, Buy Or Wait? - Trefis

Oct 27, 2025
pulisher
Oct 26, 2025

Puma Biotechnology (NASDAQ:PBYI) Downgraded to Hold (C+) Rating by Weiss Ratings - MarketBeat

Oct 26, 2025
pulisher
Oct 23, 2025

Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2025 Financial Results - BioSpace

Oct 23, 2025
pulisher
Oct 23, 2025

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results - The AI Journal

Oct 23, 2025
pulisher
Oct 22, 2025

Puma Biotechnology targets $192M-$198M NERLYNX revenue for 2025 amid strategic efforts - MSN

Oct 22, 2025
pulisher
Oct 22, 2025

Why Puma Biotechnology Inc. is moving todayJuly 2025 Earnings & AI Enhanced Market Trend Forecasts - newser.com

Oct 22, 2025

Finanzdaten der Puma Biotechnology Inc-Aktie (PBYI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie PBYI

biotechnology RPRX
$37.30
price down icon 0.64%
biotechnology GMAB
$28.71
price up icon 0.35%
biotechnology INCY
$101.57
price up icon 8.65%
biotechnology BNTX
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
biotechnology INSM
$186.23
price down icon 1.78%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):